术前与术后放化疗的局部进展期直肠癌患者肛门功能对比分析
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Comparative analysis of anal functions in patients with locally advanced rectal cancer receiving preoperative versus postoperative chemoradiotherapy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨不同放化疗时机(术前或术后)对局部进展期直肠癌(LARC)患者根治性直肠癌切除术后肛门功能及造口结局的影响。方法 回顾性纳入2000年1月-2020年5月于我院接受放化疗联合根治性直肠癌切除术的LARC患者。将患者分为术前放化疗组(术前接受新辅助放化疗)与术后放化疗组(术后接受辅助放化疗)。主要研究终点为术后2年的肛门功能(采用Wexner肛门失禁评分评估),次要研究终点为接受回肠造口还纳手术的患者比例。结果 共562例患者符合纳入条件并完成2年及以上随访,包括术前放化疗组247例、术后放化疗组315例。共422例完整填写了Wexner肛门失禁评分量表,术后2年随访时,术后放化疗组Wexner肛门失禁评分低于术前放化疗组[(2.3±4.3)分 vs (5.3±3.5)分,P<0.01],表明术后放化疗组在肛门功能方面表现更优。经倾向评分匹配平衡混杂因素后,术后放化疗组与术前放化疗组Wexner肛门失禁评分差异依然存在[(2.3±4.3)分 vs (5.3±3.5)分,P<0.01]。完成2年及以上随访的患者中有481例接受了临时性回肠造口术,其中369例在术后2年内成功还纳。多因素logistic回归分析表明,放化疗时机是临时性回肠造口术及后续造口还纳的独立预测因素(OR=0.07,95%CI 0.03~0.18,P<0.01;OR=3.45,95%CI 2.08~5.56,P<0.01)。结论 在LARC患者中,术后辅助放化疗较术前新辅助放化疗降低了临时性回肠造口率、提高了造口还纳率,并与更好的长期肛门功能相关。

    Abstract:

    Objective To explore the effects of different chemoradiotherapy timing (preoperative or postoperative) on anal functions and stoma outcomes after radical resection for locally advanced rectal cancer (LARC). Methods LARC patients who received chemoradiotherapy combined with radical rectal cancer resection at our hospital between Jan. 2000 and May 2020 were retrospectively enrolled. Patients were assigned to preoperative chemoradiotherapy group (receiving neoadjuvant chemoradiotherapy before surgery) or postoperative chemoradiotherapy group (receiving adjuvant chemoradiotherapy after surgery). The primary endpoint was overall anorectal function at 2 years postoperatively, assessed using the Wexner incontinence score. Secondary endpoints were the proportion of patients undergoing ileostomy reversal surgery. Results A total of 562 patients were enrolled and completed follow-up of at least 2 years, including 247 in the preoperative chemoradiotherapy group and 315 in the postoperative chemoradiotherapy group. The Wexner incontinence scale was fully completed by 422 patients. The 2-year postoperative Wexner score was significantly lower in the postoperative chemoradiotherapy group than in the preoperative group (2.3±4.3 vs 5.3±3.5, P<0.01), indicating better anal function in the postoperative chemoradiotherapy group. After confounding factors were balanced via propensity score matching, the significant difference in Wexner scores remained between the 2 groups (2.3±4.3 vs 5.3±3.5, P<0.01). Among all patients followed up, 481 underwent temporary ileostomy, and 369 underwent successful stoma reversal within 2 years after surgery. Multivariate logistic regression analysis revealed that chemoradiotherapy timing was an independent predictor of temporary ileostomy (OR=0.07, 95%CI 0.03-0.18, P<0.01) and subsequent stoma reversal (OR=3.45, 95%CI 2.08-5.56, P<0.01). Conclusion In LARC patients, postoperative adjuvant chemoradiotherapy, compared to preoperative neoadjuvant chemoradiotherapy, significantly reduces temporary ileostomy rates, improves stoma reversal rates, and is associated with better long-term anal function.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-04-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-09-21
  • 出版日期: 2026-09-20
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭